A Study to go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Received a Medicine Called Sunitinib Responded to This Medicine.

NCT05745142 · clinicaltrials.gov ↗

COMPLETED

Status

376

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Renal Cell
Clear-cell Metastatic Renal Cell Carcinoma

Interventions

DRUG: Sunitinib

Sponsor

Pfizer